医院再入院减少计划下预防慢阻肺再入院的进展与挑战
本文综述了医院再入院减少计划(HRRP)将慢阻肺(COPD)列为目标疾病后的影响。基于电子健康记录的捆绑照护和吸入器教育显示可减少再入院,而肺康复、随访和自助管理项目效果不一致。
要点
- HRRP将COPD列为目标后,多种预测模型被开发以识别可干预危险因素。
- 捆绑照护和吸入器教育可减少再入院,肺康复和随访效果不一致。
- COPD成为公共卫生优先事项,但仍无单一干预能可靠预防再入院。
核心结论
- HRRP实施后COPD再入院率可能下降,但至今无单一干预能可靠预防再入院。
- 需要进一步研究政策的长期效果、竞争风险在质量测量中的作用及最佳出院后照护。
研究设计与样本
- 本文为综述,总结HRRP对COPD再入院的影响及相关预测模型和干预研究。
主要发现
- 有证据表明医院为响应HRRP广泛实施的政策可能在COPD被列为目标前已降低再入院率。
- 基于电子健康记录的捆绑照护和吸入器教育干预显示可减少再入院。
- 肺康复、随访和自助管理项目未一致显示减少再入院。
临床怎么用
- 可考虑使用基于电子健康记录的捆绑照护和吸入器教育来减少COPD再入院。
- 肺康复、随访和自助管理项目对再入院的效果尚不明确,需个体化决策。
局限性
- COPD成为HRRP目标5年后,仍无单一干预能可靠预防再入院。
- 需要进一步研究政策长期效果、竞争风险在质量测量中的作用及最佳出院后照护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Hospital Readmissions Reduction Program (HRRP) was developed and implemented by the Centers for Medicare & Medicaid Services to curb the rate of 30-day hospital readmissions for certain common, high-impact conditions. In October 2014, COPD became a target condition for which hospitals were penalized for excess readmissions. The appropriateness, utility, and potential unintended consequences of the metric have been a topic of debate since it was first enacted. Nevertheless, there is evidence that hospital policies broadly implemented in response to the HRRP may have been responsible for reducing the rate of readmissions following COPD hospitalizations even before it was added as a target condition. Since the addition of the COPD condition to the HRRP, several predictive models have been developed to predict COPD survival and readmissions, with the intention of identifying modifiable risk factors. A number of interventions have also been studied, with mixed results. Bundled care interventions using the electronic health record and patient education interventions for inhaler education have been shown to reduce readmissions, whereas pulmonary rehabilitation, follow-up visits, and self-management programs have not been consistently shown to do the same. Through this program, COPD has become recognized as a public health priority. However, 5 years after COPD became a target condition for HRRP, there continues to be no single intervention that reliably prevents readmissions in this patient population. Further research is needed to understand the long-term effects of the policy, the role of competing risks in measuring quality, the optimal postdischarge care for patients with COPD, and the integrated use of predictive modeling and advanced technologies to prevent COPD readmissions.
引用
- Press VG, Myers LC, Feemster LC, et al. Preventing COPD Readmissions Under the Hospital Readmissions Reduction Program: How Far Have We Come? Chest. 2020. PMID: 33065106. doi:10.1016/j.chest.2020.10.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。